EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Clinical trial NCT02942160 · COMPLETED
Trial details
- NCT number
- NCT02942160
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-05
- Primary completion
- 2018-06-14
- Enrollment
- 259
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.